Jesse Goodman

News / Photos

1 of 2

HOUSE HEARING ON FLU VACCINE

Centers for Disease Control and Prevention director Dr. Julie Gerberding and and Food and Drug Administration Center for Biologics Evaluation and Research Director Dr. Jesse Goodman give testimony during a House Committee on Government Reform hearing on Thursday, Feb. 10, 2005, in Washington. Gerberding gave an update about the status of flu vaccines. (UPI Photo/Kamenko Pajic)

License photo

Enlarge

UPI Related News

FDA OKs new adhesive to treat burn victims

WASHINGTON, March 20 (UPI) -- The U.S. Food and Drug Administration approved a medical adhesive -- a fibrin sealant called Artiss -- for use in attaching skin grafts to burn patients.

FDA approves new hemophilia treatment

WASHINGTON, Feb. 21 (UPI) -- The U.S. Food and Drug Administration approved a new treatment for hemophilia A -- a rare, hereditary blood-clotting disorder.

FDA OKs novel surgical clotting solution

WASHINGTON, Jan. 17 (UPI) -- The U.S. Food and Drug Administration announced approval Thursday of the first clotting solution made using recombinant DNA techniques.

FDA expands use of bleeding sealant

WASHINGTON, Jan. 16 (UPI) -- The U.S. Food and Drug Administration has expanded use of a liquid protein sealant to help control bleeding during general surgery.

FDA approves blood typing tests

WASHINGTON, Jan. 14 (UPI) -- The U.S. Food and Drug Administration has licensed 14 new tests for determining a person's blood type.

FDA changes Humate-P storage conditions

WASHINGTON, Oct. 22 (UPI) -- The U.S. Food and Drug Administration approved a change in the storage conditions for Humate-P, used by people with hemophilia A or von Willebrand Disease.

FDA OKs nasal flu vaccine for children

WASHINGTON, Sept. 19 (UPI) -- The U.S. Food and Drug Administration has approved expanding the use of the nasal influenza vaccine FluMist to include children 2-5 years old.

FDA approves blood platelet bacterial test

WASHINGTON, Sept. 18 (UPI) -- The U.S. Food and Drug Administration has approved for marketing the first pretransfusion rapid blood platelet bacterial contamination test.

FDA approves second West Nile Virus test

WASHINGTON, Aug. 29 (UPI) -- The U.S. Food and Drug Administration has approved a second screening test for West Nile Virus disease for use in donated blood and organs.

FDA approves use of surgical sealant

WASHINGTON, May 15 (UPI) -- The U.S. Food and Drug Administration has approved Evicel Fibrin Sealant, a liquid coagulant used during surgical procedures.

1 of 3 Prev | Next

Related Topics